Learn More about the Annual Women’s Health Conference
Time | Topic |
---|---|
7:30 - 8:00 | Registration, Exhibits & Continental Breakfast |
8:00 - 8:50 | Psychological Perspectives on Perinatal Anxiety Disorders Abbey Kruper, PsyD |
8:50 - 9:40 | Controversies in Menopause Management Vanessa M. Barnabei MD, PhD |
9:40 - 10:10 | EXHIBIT BREAK |
10:10 - 11:00 | Care for Transgendered Patient: Providing Competent and Compassionate Care During a Time of Transition Jessica Francis, MD |
11:00 - 11:50 | Diagnosis and Therapy of Chronic Vulvovaginal Symptoms Kelly Rae Hodges, MD |
11:50 - 12:35 | EXHIBIT BREAK & LUNCH |
12:35 - 1:25 | Best Practices in Opiate Prescribing Cresta Jones, MD |
1:25 - 2:15 | Lifestyle Recommendations for Breast and Endometrial Cancer Prevention Liz Gorecki, RD, CSO, CD, CNSC Clinical Dietitian |
2:15 - 2:45 | EXHIBIT BREAK |
2:45 - 3:35 | The Many Faces of Eating Disorders Keisha Adams, MD and Tasneem Alaqzam, MD Adolescent Medicine Fellows |
3:35 - 3:40 | DRAWING FOR GIVEAWAYS |
3:40 - 4:30 | Safe in Pregnancy Kate Dielentheis, MD |
4:30 | DRAWING FOR GIVEAWAYS & WRAP UP |
We have multiple faculty who will be presenting their research posters at MCW’s 2017 Innovations in Medical Education Conference.
Care of transgender patients requires providers to be aware of issues specific to this population. A multidisciplinary approach is essential for a safe and effective transition. This symposium addresses the counseling, hormone treatment as well as surgical options available to transgender patients.
Time | Topic |
---|---|
7:30 - 8:00 AM | Introduction and Case Discussions |
8:00 - 9:00 AM | Loren S. Schechter, MD - "Surgical Aspects of Transgender Care" Board Certified plastic surgeon specializing in Gender Confirmation Surgery |
9:00 - 10:00 AM | Pat Connors, MA, LMFT, LCSW - Mental Health Care |
10:00 - 11:00 AM | Jessica Francis, MD and Raj Narayan, MD - Hormone Therapy |
MCW’s Global Health week is November 27-December 1, 2017. It was created to:
1) Increase the visibility of faculty’s global health activities in community engagement, clinical care, education, and research.
2) Raise awareness of local and international partnerships that are addressing global health issues from neighborhoods to nations.
The Department of Obstetrics & Gynecology has a long history of global health involvement. Current faculty members have traveled to provide global health care for women in multiple countries. These experiences have enriched their careers and provided unique experiences. Residents are encouraged to partake in experiences abroad during their training as well.
Panel Objectives:
– Review the variety of experiences that OBGYN practitioners have had abroad
– Listen to personal stories of meaningful experiences during global health work in women’s health
– Learn about the professional impact one gets from traveling abroad and providing health care
– Hear what an ideal vision of global health education in residency looks like from a variety of practitioners
Maternal Fetal Medicine specialist who has a special interest in global health. She’s spent time as a trainee (both as a medical student and resident) in Guatemala, Malawi and Kenya. She considers herself an advocate for global health during medical education and hopes to advocate for residents and students to gain obstetric experiences internationally.
General OB/GYN with subspecialty training in Adolescent Gynecology who has a very special interest in global health. She created our department’s “International Scholars in Obstetrics and Gynecology Program” with our first connection being with Shijiazhuang City Maternity and Child Health Hospital.
General OB/GYN with subspecialty training in Family Planning. She has a special interest in global health teaching and clinical care, focusing on improving women’s health outcomes through improving access to safe and comprehensive family planning services. She has taught and provided clinical services in Africa, Asia, and Central America.
MCW OB/GYN resident graduate of 2017 and a current generalist in Obstetrics and Gynecology through Columbia St. Mary’s Hospital. She has an interest in global health primarily in Central and South America and has created the Global Health Resident Travel Fund in the Department of Obstetrics & Gynecology to promote resident education in global health. She volunteers as a provider and educator at CerviCusco in Cusco, Peru to address their high rates of cervical cancer morbidity and mortality. She also serves on the Board of Directors for the International Cervical Cancer Foundation
Learn More about the Annual Women’s Health Conference
Please join us for a cafe conversation led by Andrew Petroll, MD and Jessica Francis, MD on “Understanding Gender Identity: Taking a Deeper Dive”. All students, faculty, and staff are welcome to join us.
Come and listen to our panelists tell their stories about the barriers trans and gender non-conforming patients may face while seeking health care, and ways to show compassion and provide quality care. This program is designed for our clinical faculty and students but is open to all.
Jennifer McIntosh, DO, MS
Assistant Professor, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine
Medical College of Wisconsin
Maternal and neonatal morbidity and mortality caused by preeclampsia is a significant global health burden with approximately 10 million pregnancies impacted resulting in nearly half a million fetal or neonatal lives lost each year. A novel relationship may exist between mitochondrial damage and endothelial dysfunction and subsequent development of preeclampsia.
Our overall goal is to investigate the mechanism whereby placental hypoxia is responsible for release of ROS and inflammation secondary to mitochondrial DNA (mtDNA) and if there is altered FMD as a result of heightened mtDNA in vessels from placentas in those with preeclampsia.
CARDIOVASCULAR CENTER MEMBER PRESENTATION
Jenn McIntosh, DO, MS – Perinatologist
Please join us virtually! We will discuss what preeclampsia is and the signs and symptoms to watch for in pregnancy, as well as how it’s managed.
We will also explain the impact of preeclampsia on a woman’s future heart health.
Presentation by: Jennifer Jury McIntosh, DO, Perinatologist
Register online through the link to Froedtert’s classes and events below.
Join us September 25th for the Ray of Hope’s 3rd Annual Race! Help us run or walk to raise funds for ovarian cancer. All proceeds go directly to our researchers working hard to identify novel targets and treatment strategies to cure ovarian cancer.
Ray of Hope is a non-profit organization established in 2018 in the Greater Milwaukee Area in response to the need for more advocacy for ovarian cancer awareness and research. Ray of hope provides philanthropic support to ovarian cancer researchers like us to generate preliminary data to apply for high-risk and high-reward federal grants. Ray of hope believes in the bravery of all women who have fought or are fighting against ovarian cancer. Ray of hope is working for women around the globe to be brave and resilient in the fight against ovarian cancer – – and their bravery should not go unnoticed.
Sunila Pradeep, PhD’s laboratory is partnering in the mission of Ray of Hope by identifying novel targets and treatment strategies to cure ovarian cancer.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Bo Wang, PhD
Director – Tissue Regenerative Engineering Laboratory (TRE Lab)
Assistant Professor – Department of Biomedical Engineering, The Marquette University and Medical College of Wisconsin
Dr. Bo Wang, Director and Principal Investigator of the TRE Lab, received her PhD in Biomedical Engineering from Mississippi State University in 2012 and completed her Postdoctoral Fellowship at Northwestern University’s Feinberg School of Medicine, Department of Surgery, in 2016. She joined the Marquette-MCW Joint Department of Biomedical Engineering in January of 2019 with research interests that include stem cell engineering, hard-tissue engineering and 3D bioprinting, as well as vascular tissue engineering, imaging, modeling and simulation.
The Tissue Regenerative Engineering Laboratory is developing bio-functional engineered tissues that provide advanced therapeutic options for such conditions as birth defects, bone disorders, and liver and vascular diseases. To do this, the TRE Lab will first develop a greater understanding of the biological and molecular processes involved in regenerative regression.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=””][vc_column][vc_column_text]
Navonil De Sarkar, PhD
Assistant Professor – Department of Pathology at the Medical College of Wisconsin
Navonil De Sarkar is an Assistant Professor at the Medical College of Wisconsin Cancer Center with a dual background in computational and experimental genomics; he brings a multidisciplinary approach to studying human cancers. His research focuses on understanding the natural history of the disease, devising noninvasive approaches to track adaptive and molecular evolutionary changes in cancer accurately, and ultimately developing practical strategies for precision medicine in advanced cancer patients (Augmented precision medicine).
Navonil received his Ph.D. from the Indian Statistical Institute and joined Peter Nelson’s lab at the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, for postdoctoral training. Through adopting integrative genomics approaches, Navonil developed extensive experience analyzing tumor genomes to study functionally relevant mutations and structural aberrations using tumor tissue and circulating tumor DNA (ctDNA). Navonil participated in several large-scale consortium data analyses, including Stat-up-to-cancer germline and prostate tumor analysis efforts. Navonil led the bioinformatics analysis of the large-scale germline sequence work that highlighted the importance of inherited DNA repair genes in shaping the fate of advanced prostate cancer. He is one of the early discoverers of CDK12 loss-associated tandem duplicator signature. Subsequently, De Sarkar developed a machine learning-based classifier that accurately predicts functional homologous recombination deficiency. Recently, he co-led a study interrogating whole genomes of advanced prostate cancers using cell-free DNA sequencing and discovered imprints of cancer epigenomes in native cell-free DNA sequence data.
Navonil is a recipient of several trainee awards. To mention in 2019 Navonil received the very competitive Prostate Cancer Foundation Young Investigator Award. Then onwards, Navonil is co-leading Prostate Cancer Foundation DNA repair-focused working group activities. He is the editorial board member for Translational Oncology and an associate editor for the Genitourinary Oncology edition of Frontiers journals.
Navonil re-joined MCW in March 2023 and committed to establishing a multidisciplinary research group to develop cutting-edge but practical precision medicine tools for prostate and other cancers. Building on strong biological fundamentals and detailed understandings of the disease, De Sarkar Lab (DeTAnomics Lab) is developing novel therapeutic strategies and working to co-develop new genomic assays and computational genomics tools to help us tackle the most lethal types of prostate and other cancers. DeTAnomics Lab adopts long-read genomic sequencing techniques to better understand cancer genome, transcriptome, and epigenome. In the lab, DeTAnomics lab explores the complex interplay between the genome and epigenome to uncover new insights that can lead to the development of more effective therapeutics and biomarkers. Currently, DeSarkar and his team are working on developing a practical strategy to degrade BRCA2 in tumor cells so as to confer DNA-damaging mediated therapy benefits to a wider pool of patients.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]